New Light-Based sensors could spot hidden heart defects in newborns
NCT ID NCT05880576
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study tests whether combining standard monitoring tools with new light-based sensors can better detect a dangerous narrowing of the aorta in newborns. Infants under one month old with suspected aortic arch obstruction will be monitored using resonance Raman spectroscopy, pulse oximetry, blood pressure, and near-infrared spectroscopy. The goal is to improve early diagnosis and prevent life-threatening complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better, non-invasive ways to detect dangerous heart blockages in newborns, potentially saving lives by enabling earlier treatment.
- What could go wrong
- This is an early-stage observational study with only 60 infants, so results may not apply to all newborns. The new monitoring tools may not prove more effective than current methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC ARCH OBSTRUCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.